Cabot Corp. (CBT) Tops Q3 EPS by 2c; tightens guidance
Tweet
Share
E-mail
Get Alerts CBT Hot Sheet
Price: $81.27 -0.26%
EPS Growth %: -10.0%
Financial Fact:
Other (expense) income: 1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -10.0%
Financial Fact:
Other (expense) income: 1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cabot Corp. (NYSE: CBT) reported Q3 EPS of $1.67, $0.02 better than the analyst estimate of $1.65. Revenue for the quarter came in at $982 million versus the consensus estimate of $927.44 million.
GUIDANCE:
Cabot Corp. sees FY2026 EPS of $6.15-$6.45, versus the consensus of $6.34.
For earnings history and earnings-related data on Cabot Corp. (CBT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) call put ratio 2.3 calls to 1 put with a focus on October calls into quarter results
- CANEX Increases Equity Financing to C$9 Million
- Roivant Sciences (ROIV) PT Raised to $52 at Jefferies
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
